Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Selected Subjects With Advanced Solid Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07814248
What this trial is testing

A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)HNSCCEndometrial+5 more
TwoStep Therapeutics, Inc. 74
Testing effectiveness (Phase 2)Active Not RecruitingNCT02671435
What this trial is testing

Durvalumab (MEDI4736) and Monalizumab in Solid Tumors

Who this might be right for
Advanced Solid Tumors
MedImmune LLC 383
Early research (Phase 1)Study completedNCT02318394
What this trial is testing

MEDI0562 in Adult Subjects With Selected Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
MedImmune LLC 56
Testing effectiveness (Phase 2)Looking for participantsNCT06725758
What this trial is testing

A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours

Who this might be right for
Solid Tumours
Orion Corporation, Orion Pharma 315
Testing effectiveness (Phase 2)Study completedNCT04856774
What this trial is testing

Trial of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors

Who this might be right for
Advanced Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 81
Early research (Phase 1)Ended earlyNCT02698176
What this trial is testing

A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Advanced Solid Tumors (MK-8628-006)

Who this might be right for
NUT Midline Carcinoma (NMC)Triple Negative Breast Cancer (TNBC)Non-small Cell Lung Cancer (NSCLC)+1 more
Merck Sharp & Dohme LLC 13
Early research (Phase 1)Ended earlyNCT05827614
What this trial is testing

Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

Who this might be right for
Triple Negative Breast Cancer (TNBC)High Grade Serous Ovarian CarcinomaHigh Grade Endometrial Carcinoma+9 more
Boundless Bio, Inc. 85
Testing effectiveness (Phase 2)Study completedNCT02318277
What this trial is testing

Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors (ECHO-203)

Who this might be right for
Solid TumorsHead and Neck CancerLung Cancer+1 more
Incyte Corporation 176
Early research (Phase 1)Study completedNCT02937116
What this trial is testing

First in Human Study of IBI308 in Chinese Subjects With Advanced Solid Tumors

Who this might be right for
Cancer, Solid Tumor
Innovent Biologics (Suzhou) Co. Ltd. 233
Early research (Phase 1)Study completedNCT02576548
What this trial is testing

MEDI4276 in Adults Subjects With Select HER2-expressing Advanced Solid Tumors.

Who this might be right for
HER2 Expressing Breast or Gastric/Stomach Cancers
MedImmune LLC 47
Early research (Phase 1)Study completedNCT03889275
What this trial is testing

MEDI5395 in Combination With Durvalumab in Participants With Select Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
MedImmune LLC 39
Early research (Phase 1)Study completedNCT02723955
What this trial is testing

Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)

Who this might be right for
Neoplasms
GlaxoSmithKline 829
Early research (Phase 1)Study completedNCT01772004
What this trial is testing

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

Who this might be right for
Solid Tumors
EMD Serono Research & Development Institute, Inc. 1,756
Early research (Phase 1)Ended earlyNCT00585845
What this trial is testing

Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment

Who this might be right for
Malignant Epithelial MesotheliomaAdenocarcinoma of the PancreasCarcinoma, Non-Small-Cell Lung+1 more
Anza Therapeutics, Inc. 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT05631262
What this trial is testing

SKB264 Monotherapy in Selected Subjects With Advanced Solid Tumors

Who this might be right for
Selected Subjects With Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 321
Early research (Phase 1)Study completedNCT00729664
What this trial is testing

Multiple Ascending Dose (MDX1105-01)

Who this might be right for
Cancer, Multiple Indications
Bristol-Myers Squibb 281
Testing effectiveness (Phase 2)UnknownNCT04974957
What this trial is testing

Study of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors

Who this might be right for
Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 71
Testing effectiveness (Phase 2)Looking for participantsNCT05877430
What this trial is testing

Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer

Who this might be right for
NSCLCHNSCCMelanoma+3 more
CJ Bioscience, Inc. 160
Early research (Phase 1)Study completedNCT02296879
What this trial is testing

A Multicenter, Open Label, Phase I Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous SAIT301 in Subjects With Advanced c-MET Positive (+) Solid Tumors Followed by Expansion in Selected Tumor Types

Who this might be right for
Solid Tumors
Young Suk Park 16
Early research (Phase 1)Ended earlyNCT06299761
What this trial is testing

Study of the RNR Inhibitor BBI-825 in Subjects With Tumors With Resistance Gene Amplifications

Who this might be right for
Solid Tumor
Boundless Bio, Inc. 19
Next Page